CALD1

Caldesmon · Q05682 · CALD1 on Sugi Atlas →

0 patent compounds predicted against CALD1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CALD1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors PHASE1COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy nanNOT_YET_RECRUITING
Characteristics of Nondystrophic Myotonias nanCOMPLETED
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy nanACTIVE_NOT_RECRUITING
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms nanCOMPLETED
Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy nanCOMPLETED
Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies nanRECRUITING
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia nanCOMPLETED
A Natural History Study of RYR1-Related Disorders nanRECRUITING
CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD nanENROLLING_BY_INVITATION
Congenital Muscle Disease Study of Patient and Family Reported Medical Information nanRECRUITING
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Decoding the Genetic Landscape of Skeletal Diseases nanRECRUITING
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) nanCOMPLETED
McArdle Disease Treatment by Ketogenic Diet nanCOMPLETED
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia nanUNKNOWN
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study nanRECRUITING
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Brain Involvement in Dystrophinopathies Part 2 nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development nanRECRUITING
Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS nanNOT_YET_RECRUITING
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CALD1 binder may also engage these)

ProteinNameSimilarity
P12957 0.995 P12957 →
D4A4L4 0.989 D4A4L4 →
Q62736 0.989 Q62736 →
Q7TPW1 0.988 Q7TPW1 →
Q0IHP2 0.987 Q0IHP2 →
Q9WU62 0.987 Q9WU62 →
Q05D44 0.986 Q05D44 →
Q96T17 0.986 Q96T17 →
Q5RG44 0.985 Q5RG44 →
EIF5B Eukaryotic translation initiation factor 5B 0.984 landscape →
O75167 0.984 O75167 →
A0JMK9 0.984 A0JMK9 →
Q9ERH4 0.983 Q9ERH4 →
Q0ZGT2 0.983 Q0ZGT2 →
Q9NQW6 0.983 Q9NQW6 →
Q9LFE0 0.983 Q9LFE0 →
O60237 0.983 O60237 →
Q32N93 0.982 Q32N93 →
F1QIC4 0.982 F1QIC4 →
Q5RDE1 0.982 Q5RDE1 →
B2GUV7 0.982 B2GUV7 →
Q8IZ21 0.982 Q8IZ21 →
Q9JHU2 0.982 Q9JHU2 →
Q8BG95 0.982 Q8BG95 →
EPB41L2 Band 4.1-like protein 2 0.982 landscape →
P13505 0.981 P13505 →
Q3TRR0 0.981 Q3TRR0 →
Q8NDI1 0.981 Q8NDI1 →
Q6Y7W8 0.981 Q6Y7W8 →
Q49MG5 0.981 Q49MG5 →